About Abtek Biologicals
Abtek Biologicals is a Healthcare company based in Liverpool (United Kingdom) founded in 1981, and was acquired by Neogen in February 2020. Manufacturer of reagents and dyes kits for research purposes. The company has 9 employees. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Probes and Dyes. Its legal entity is SENTINELONE, INC. Its competitors include ATDBio and DestiNA Genomics; 1 of its 2 listed competitors has raised funding.
Company details
Abtek Biologicals was established in 1981 and is based in Liverpool, United Kingdom. Reagents and dye kits intended for research applications are produced by the company within the biotechnology sector. Manufacturing operations are centered on developing tools for scientific investigations, with distribution handled through the domain abtekbio.com. Focus remains on supporting laboratory needs in biological research across various geographies.
- Headquarters Liverpool, United Kingdom
- Employees 9
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website abtekbio.com
- Social LinkedIn X
- Acquired by Neogen (Feb 2020)
- Legal Name Sentinelone, Inc.
Investors in Abtek Biologicals
Abtek Biologicals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Neogen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | 1982 | neogen.com | Lansing, United States |
Investor details for Abtek Biologicals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Abtek Biologicals
2 dated milestones of Abtek Biologicals across 39 years, from founding to its latest funding, stage changes and deals.
- Founded Abtek Biologicals is founded.
- Exit Acquired by Neogen.
Competitors of Abtek Biologicals
Abtek Biologicals has 2 listed competitors in our database, 1 of them funded. They include ATDBio and DestiNA Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atdbio.com | 2005 | Southampton, United Kingdom | 23 | Developer of oligonucleotides | ||
| destinagenomics.com | 2010 | Edinburgh, United Kingdom | $1.9M | 2 | Non-enzymatic nucleic acid detection technology is developed using DGL probes. |
Detailed competitors of Abtek Biologicals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Abtek Biologicals
Websites that share an audience with Abtek Biologicals (abtekbio.com).
Websites whose visitors overlap most with Abtek Biologicals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| google.com | 100% | 85.8B | #1 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Abtek Biologicals (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Abtek Biologicals
Complete news archive for Abtek Biologicals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abtek Biologicals
Abtek Biologicals was founded in 1981.
Abtek Biologicals is headquartered in Liverpool, United Kingdom.
Abtek Biologicals has 9 employees.
Abtek Biologicals was established in 1981 and is based in Liverpool, United Kingdom. Reagents and dye kits intended for research applications are produced by the company within the biotechnology sector. Manufacturing operations are centered on developing tools for scientific investigations, with distribution handled through the domain abtekbio.com. Focus remains on supporting laboratory needs in biological research across various geographies.
Abtek Biologicals's top competitors include ATDBio and DestiNA Genomics.
Abtek Biologicals has 1 investor. Key investors include Neogen.
Abtek Biologicals operates through Sentinelone, Inc..
Yes. Abtek Biologicals was acquired by Neogen in February 2020.